Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.75 - $1.33 $14,107 - $25,017
-18,810 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$1.29 - $4.04 $1,707 - $5,348
-1,324 Reduced 6.58%
18,810 $25,000
Q4 2021

Feb 11, 2022

SELL
$3.45 - $6.05 $2,080 - $3,648
-603 Reduced 2.91%
20,134 $78,000
Q3 2021

Nov 12, 2021

BUY
$5.53 - $9.28 $2,272 - $3,814
411 Added 2.02%
20,737 $116,000
Q2 2021

Aug 13, 2021

SELL
$7.84 - $12.6 $3,010 - $4,838
-384 Reduced 1.85%
20,326 $181,000
Q1 2021

May 07, 2021

BUY
$10.54 - $19.3 $26,876 - $49,215
2,550 Added 14.04%
20,710 $263,000
Q4 2020

Feb 12, 2021

SELL
$12.79 - $17.1 $6,676 - $8,926
-522 Reduced 2.79%
18,160 $253,000
Q3 2020

Nov 04, 2020

SELL
$12.99 - $19.41 $2,727 - $4,076
-210 Reduced 1.11%
18,682 $243,000
Q2 2020

Aug 12, 2020

BUY
$12.19 - $22.96 $61,132 - $115,144
5,015 Added 36.14%
18,892 $330,000
Q1 2020

May 04, 2020

BUY
$10.08 - $27.21 $9,807 - $26,475
973 Added 7.54%
13,877 $216,000
Q4 2019

Feb 05, 2020

SELL
$13.05 - $21.88 $1,422 - $2,384
-109 Reduced 0.84%
12,904 $260,000
Q3 2019

Nov 08, 2019

BUY
$14.12 - $23.44 $42,938 - $71,281
3,041 Added 30.5%
13,013 $184,000
Q2 2019

Aug 13, 2019

BUY
$13.21 - $27.29 $24,583 - $50,786
1,861 Added 22.94%
9,972 $162,000
Q1 2019

May 06, 2019

BUY
$12.46 - $22.05 $51,086 - $90,405
4,100 Added 102.22%
8,111 $179,000
Q4 2018

Feb 13, 2019

SELL
$15.43 - $32.7 $462 - $981
-30 Reduced 0.74%
4,011 $67,000
Q3 2018

Nov 09, 2018

BUY
$26.95 - $52.7 $108,904 - $212,960
4,041 New
4,041 $210,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0

About AVROBIO, Inc.


  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.